BB Biotech AG

Headquarters: Kusnacht, Switzerland

Employees: 10

SIX: BION -0.84%

Market Cap

CHF2.39 Billion

CHF as of Jan. 1, 2024

US$2.84 Billion

Market Cap History

BB Biotech AG market capitalization over time

Evolution of BB Biotech AG market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of BB Biotech AG

Detailed Description

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

BB Biotech AG has the following listings and related stock indices.

Stock: SIX: BION wb_incandescent

Stock: MTA: BB wb_incandescent

Stock: OTC: BBAGF wb_incandescent



Seestrasse 16

Kusnacht, 8700


Phone: 41 44 267 67 00

Fax: 41 44 267 67 01